Single‐center experience with bimekizumab in psoriasis patients with previous exposure to interleukin‐17 inhibitors
Year: 2024
Type: article
DOI: 10.1111/ijd.17630
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,950
OpenAlex ID: W4405922091
